View in EDS HTML Full Text PDF Full Text

Exploring the therapeutic potential of precision T-Cell Receptors (TCRs) in targeting KRAS G12D cancer through in vitro development.

Saved in:
Bibliographic Details
Title: Exploring the therapeutic potential of precision T-Cell Receptors (TCRs) in targeting KRAS G12D cancer through in vitro development.
Authors: Zheng W; Sino-German Biomedical Center, National '111' Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education of China & Hubei Province), Hubei University of Technology, Wuhan, 430068, China., Jiang D; Center of Research & Development, Beijing CorreGene Biotechnology Co., Ltd., Beijing, 102206, China., Chen S; Sino-German Biomedical Center, National '111' Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education of China & Hubei Province), Hubei University of Technology, Wuhan, 430068, China., Wu M; Sino-German Biomedical Center, National '111' Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education of China & Hubei Province), Hubei University of Technology, Wuhan, 430068, China., Yan B; Center of Research & Development, Beijing CorreGene Biotechnology Co., Ltd., Beijing, 102206, China., Zhai J; Center of Research & Development, Beijing CorreGene Biotechnology Co., Ltd., Beijing, 102206, China., Shi Y; Center of Research & Development, Beijing CorreGene Biotechnology Co., Ltd., Beijing, 102206, China., Xie B; Sino-German Biomedical Center, National '111' Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education of China & Hubei Province), Hubei University of Technology, Wuhan, 430068, China., Xie X; Center of Research & Development, Beijing CorreGene Biotechnology Co., Ltd., Beijing, 102206, China., Hu K; Sino-German Biomedical Center, National '111' Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education of China & Hubei Province), Hubei University of Technology, Wuhan, 430068, China., Ma W; Department of Medicine, Sanford Stem Cell Institute and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
Source: Oncology research [Oncol Res] 2024 Nov 13; Vol. 32 (12), pp. 1837-1850. Date of Electronic Publication: 2024 Nov 13 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Tech Science Press Country of Publication: United States NLM ID: 9208097 Publication Model: eCollection Cited Medium: Internet ISSN: 1555-3906 (Electronic) Linking ISSN: 09650407 NLM ISO Abbreviation: Oncol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39574477
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Exploring the therapeutic potential of precision T-Cell Receptors (TCRs) in targeting KRAS G12D cancer through in vitro development.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zheng+W%22">Zheng W</searchLink>; Sino-German Biomedical Center, National '111' Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education of China & Hubei Province), Hubei University of Technology, Wuhan, 430068, China.<br /><searchLink fieldCode="AU" term="%22Jiang+D%22">Jiang D</searchLink>; Center of Research & Development, Beijing CorreGene Biotechnology Co., Ltd., Beijing, 102206, China.<br /><searchLink fieldCode="AU" term="%22Chen+S%22">Chen S</searchLink>; Sino-German Biomedical Center, National '111' Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education of China & Hubei Province), Hubei University of Technology, Wuhan, 430068, China.<br /><searchLink fieldCode="AU" term="%22Wu+M%22">Wu M</searchLink>; Sino-German Biomedical Center, National '111' Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education of China & Hubei Province), Hubei University of Technology, Wuhan, 430068, China.<br /><searchLink fieldCode="AU" term="%22Yan+B%22">Yan B</searchLink>; Center of Research & Development, Beijing CorreGene Biotechnology Co., Ltd., Beijing, 102206, China.<br /><searchLink fieldCode="AU" term="%22Zhai+J%22">Zhai J</searchLink>; Center of Research & Development, Beijing CorreGene Biotechnology Co., Ltd., Beijing, 102206, China.<br /><searchLink fieldCode="AU" term="%22Shi+Y%22">Shi Y</searchLink>; Center of Research & Development, Beijing CorreGene Biotechnology Co., Ltd., Beijing, 102206, China.<br /><searchLink fieldCode="AU" term="%22Xie+B%22">Xie B</searchLink>; Sino-German Biomedical Center, National '111' Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education of China & Hubei Province), Hubei University of Technology, Wuhan, 430068, China.<br /><searchLink fieldCode="AU" term="%22Xie+X%22">Xie X</searchLink>; Center of Research & Development, Beijing CorreGene Biotechnology Co., Ltd., Beijing, 102206, China.<br /><searchLink fieldCode="AU" term="%22Hu+K%22">Hu K</searchLink>; Sino-German Biomedical Center, National '111' Center for Cellular Regulation and Molecular Pharmaceutics, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education of China & Hubei Province), Hubei University of Technology, Wuhan, 430068, China.<br /><searchLink fieldCode="AU" term="%22Ma+W%22">Ma W</searchLink>; Department of Medicine, Sanford Stem Cell Institute and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229208097%22">Oncology research</searchLink> [Oncol Res] 2024 Nov 13; Vol. 32 (12), pp. 1837-1850. <i>Date of Electronic Publication: </i>2024 Nov 13 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Tech+Science+Press%22">Tech Science Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9208097 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1555-3906 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209650407%22">09650407 </searchLink><i>NLM ISO Abbreviation: </i>Oncol Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39574477
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.32604/or.2024.056565
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1837
    Titles:
      – TitleFull: Exploring the therapeutic potential of precision T-Cell Receptors (TCRs) in targeting KRAS G12D cancer through in vitro development.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zheng W
      – PersonEntity:
          Name:
            NameFull: Jiang D
      – PersonEntity:
          Name:
            NameFull: Chen S
      – PersonEntity:
          Name:
            NameFull: Wu M
      – PersonEntity:
          Name:
            NameFull: Yan B
      – PersonEntity:
          Name:
            NameFull: Zhai J
      – PersonEntity:
          Name:
            NameFull: Shi Y
      – PersonEntity:
          Name:
            NameFull: Xie B
      – PersonEntity:
          Name:
            NameFull: Xie X
      – PersonEntity:
          Name:
            NameFull: Hu K
      – PersonEntity:
          Name:
            NameFull: Ma W
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 11
              Text: 2024 Nov 13
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1555-3906
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Oncology research
              Type: main
ResultId 1